Literature DB >> 9123113

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

V Mazzaferro1, E Regalia, A Pulvirenti, A Tagger, S Andreola, M Pasquali, D Baratti, F Romano, U Palazzo, M Zuin, F Bonino, M L Ribero, L Gennari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9123113     DOI： 10.1016/s0041-1345(96)00248-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Hepatitis C and liver transplantation.

Authors:  M Berenguer; T L Wright
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

2.  Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1.

Authors:  C Li; D Candotti; J P Allain
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 3.  Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Treatment of hepatitis B and C following liver transplantation.

Authors:  Craig A Sponseller; Sanjay Ramrakhiani
Journal:  Curr Gastroenterol Rep       Date:  2002-02

Review 5.  Viral prophylaxis in organ transplant patients.

Authors:  Michelle Slifkin; Shira Doron; David R Snydman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis; Clare D Toon; Brian R Davidson; Andrew K Burroughs
Journal:  Cochrane Database Syst Rev       Date:  2013-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.